Terminal · Institutions
Every 13F-reported equity position this quarter, with its quarter-over-quarter change — each row traces back to the SEC filing.
Every 13F-reported equity position this quarter, with its quarter-over-quarter change — each row traces back to the SEC filing.
Ponoi Management, LLC (CIK 1720702) reported $73.2M across 4 reported positions in its SEC 13F filing for 2022-09-30. Largest positions: RAPT ($38.5M, 52.54%), NGM ($17.0M, 23.20%), RVMD ($13.5M, 18.44%), NRIX ($4.3M, 5.82%). Source: SEC Form 13F.
| Rank | Ticker | Company | Value | % Portfolio | Shares | Action |
|---|---|---|---|---|---|---|
| 1 | RAPT | RAPT Therapeutics Inc | $38.5M | 52.54% | 1.6M | Hold |
| 2 | NGM | NGM Biopharmaceuticals Inc | $17.0M | 23.20% | 1.3M | Hold |
| 3 | RVMD | Revolution Medicines Inc | $13.5M | 18.44% | 685,011 | Hold |
| 4 | NRIX | Nurix Therapeutics Inc | $4.3M | 5.82% | 327,123 | Hold |
Source: SEC Form 13F filings · as of 2022-09-30